US MD: FDA Approves Marijuana Based Drug

US MD: FDA Approves Marijuana Based Drug

URL: http://www.mapinc.org/drugnews/v13/n527/a03.html
Newshawk: Free The Weed
Votes: 0
Pubdate: Thu, 31 Oct 2013
Source: Montgomery County Sentinel (Rockville, MD)
Copyright: 2013 Montgomery Sentinel Publishing, Inc
Contact: [email protected]
Website: http://www.thesentinel.com
Details: http://www.mapinc.org/media/4451
Author: Bonnie Katz

FDA APPROVES MARIJUANA BASED DRUG

The U.S.  Food and Drug Administration has approved clinical trials of a cannabis-based drug and its effects on epilepsy.  The treatment, Epidiolex, is 98 percent purified cannabidiol ( CBD ) made by GW Pharmaceuticals based out of the U.K.

There are around 60 known chemicals contained in cannabis called cannabinoids.  Tetrahydrocannabinol, also known as THC, is the main component responsible for the drug’s psychoactive nature.  CBD, however, is the second most abundant cannabinoid in the cannabis and provides medicinal benefits without the “high.” Epidiolex will come in a viscous liquid form to be dispensed from syringes.  A 25 milligram per meter or 100 milligram per meter will be the two strengths made available to those in the trials.

The FDA has approved of intermediate-sized clinical trials sponsored by two doctors.  Dr.  Orrin Devinsky, a professor in the Department of Neurology, Neuroscience and Psychiatry in the New York University School of Medicine and director of the NYU Comprehensive Epilepsy Center, and Dr.  Roberta Cilio, a pediatric neurologist at the University of California, San Francisco, are set to follow 25 patients using Epidiolex as treatment for pediatric epilepsy.

On Oct.  4, at the NYU Langone Medical Center, Devinsky led a conference entitled, “Cannabidiols: Potential Use in Epilepsy & Other Neurological Disorders.” During the affair, Devinsky and Cilio led a presentation on planned trials on CBD in children with treatment resistant epilepsy.

The D.C.  – based Marijuana Policy Project’s Communications Director Mason Tvert responded to the news of the approved trials.  “We’ve long known that marijuana has a variety of medical benefits,” Tvert said.  Tvert added that the federal government clearly recognizes marijuana’s medicinal benefits and it’s a shame they hindered most research of it.

Maryland’s new marijuana law came into effect on Oct.  1, but its miniscule scope won’t have much effect.  It deals with a small number of patients that would enroll in state-approved clinical studies.  However, with no hospitals signed up to hold these studies, no visible changes are set to occur in the near future.

Now the country will wait and see if CBD can live up to the hype, and if the epileptic patients can find any relief from their disease.

US MD: FDA Approves Marijuana Based Drug.

WeedQuest.com, Know Your Weed


SickMeds Seeds

SickMeds Seeds

SickMeds Seeds passion is to share with the rest of the canna community genetics that either are no longer available, to those that are clone only that everyone wants to have, to strains developed with medicinal attributes in mind, for recreational or commercial growers, or those seeking strains developed with consideration to particular ailments.

We, as keen growers ourselves with over ten years experience have missed the opportunity at times to grow certain strains, ones we would consider to be building blocks of today’s modern strains such as those produced by Super Sativa Seed Club in the mid 80’s. Through our obsession to track down such genetics we are able to bring old lines back to life, and to be shared with everyone. To work with genetics such as our William´s Wonder to release the strain in its purist form in both regular and feminised versions.

We are now working closely with canna labs and research in order to gain further appreciation of cannabinoid qualities and properties of our strains. This allows us to develop strains with knowing what each parent will contribute in terms of cannabinoid percentages and whether these match when breeding. It also acts as means to ensure consistency in each of our releases, as quality and consistency are fundamental in our approach.

We aim to move forward and research, embrace new techniques in regards to canna technology. At present we are assessing the effectiveness of plant tissue culture. The potential that cannabis genetics are preserved and recreated. Although the theories behind these methods are not new, the practise of using these methods in the canna world are still to be explored and fully understood.

SickMeds Seeds.